Aruna D. Pradhan
Brigham and Women's Hospital · 139 works · 17,728 citations · h-index 52
Top works
- C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
- Hemoglobin A1c Predicts Diabetes but Not Cardiovascular Disease in Nondiabetic Women
- Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease
- Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
- C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women
- Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
- Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events
- Relationship of total and abdominal adiposity with CRP and IL-6 in women
- Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men
- Hemoglobin A1c Level and Future Cardiovascular Events Among Women
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- Adverse Effects of Low-Dose Methotrexate
- Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
- Symptomatic Peripheral Arterial Disease in Women
- Sex Differences in the Metabolic Syndrome: Implications for Cardiovascular Health in Women